SG104087G - Crystalline benzenesulfonate salts of sultamicillin - Google Patents

Crystalline benzenesulfonate salts of sultamicillin

Info

Publication number
SG104087G
SG104087G SG1040/87A SG104087A SG104087G SG 104087 G SG104087 G SG 104087G SG 1040/87 A SG1040/87 A SG 1040/87A SG 104087 A SG104087 A SG 104087A SG 104087 G SG104087 G SG 104087G
Authority
SG
Singapore
Prior art keywords
sultamicillin
benzenesulfonate salts
crystalline benzenesulfonate
crystalline
salts
Prior art date
Application number
SG1040/87A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SG104087G publication Critical patent/SG104087G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG1040/87A 1982-04-23 1987-11-25 Crystalline benzenesulfonate salts of sultamicillin SG104087G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/371,156 US4432987A (en) 1982-04-23 1982-04-23 Crystalline benzenesulfonate salts of sultamicillin

Publications (1)

Publication Number Publication Date
SG104087G true SG104087G (en) 1988-07-15

Family

ID=23462725

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1040/87A SG104087G (en) 1982-04-23 1987-11-25 Crystalline benzenesulfonate salts of sultamicillin

Country Status (27)

Country Link
US (1) US4432987A (ko)
EP (1) EP0092968B1 (ko)
JP (1) JPS58201792A (ko)
KR (1) KR860001279B1 (ko)
AU (1) AU536854B2 (ko)
CA (1) CA1187484A (ko)
CS (1) CS235320B2 (ko)
DD (1) DD209632A5 (ko)
DE (1) DE3362502D1 (ko)
DK (1) DK162168C (ko)
EG (1) EG16412A (ko)
ES (1) ES521728A0 (ko)
FI (1) FI76092C (ko)
GR (1) GR78582B (ko)
HK (1) HK20588A (ko)
HU (1) HU187068B (ko)
IE (1) IE54628B1 (ko)
IL (1) IL68453A (ko)
NO (1) NO156202C (ko)
NZ (1) NZ203988A (ko)
PH (1) PH18035A (ko)
PL (1) PL134978B1 (ko)
PT (1) PT76587B (ko)
SG (1) SG104087G (ko)
SU (1) SU1138030A3 (ko)
YU (1) YU43170B (ko)
ZA (1) ZA832845B (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
WO1987002893A1 (en) * 1985-11-18 1987-05-21 Board Of Regents, The University Of Texas System Polychelating agents for image and spectral enhancement (and spectral shift)
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
KR100314558B1 (ko) * 1994-05-02 2002-02-28 시오노 호히코 피롤리딜티오카르바페넴유도체의결정과,상기결정을함유한동결건조제제및그제조방법
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
NZ538956A (en) 2002-08-29 2006-08-31 Taisho Pharmaceutical Co Ltd Benzenesulfonate salt of 4-fluoro-2-cyanopyrrolidine derivative used to inhibit dipeptidyl peptidase IV (DPPIV)
AU2004224181B2 (en) * 2003-03-27 2011-06-02 Basilea Pharmaceutica Ag Cephalosporin in crystalline form
JP2007509974A (ja) * 2003-10-31 2007-04-19 アルザ・コーポレーシヨン ３−アミノプロピル−ｎ−ブチルホスフィン酸の増大した吸収のための組成物および薬用量形態
FR2877696B1 (fr) 2004-11-09 2009-09-18 Renault Sas Dispositif et procede d'estimation en temps reel de l'angle de debut de combustion d'un moteur a combustion interne
KR101588466B1 (ko) 2007-08-22 2016-01-25 아스트라제네카 아베 시클로프로필 아미드 유도체
EP2620432A3 (en) 2007-10-26 2013-12-18 The Regents Of the University of California Diarylhydantoin compounds
US20110288142A1 (en) * 2009-01-30 2011-11-24 Chen Pingyun Y CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
JP2012532886A (ja) * 2009-07-10 2012-12-20 エボルバ アクチェンゲゼルシャフト ジイン組成物
NZ602108A (en) * 2010-02-18 2014-09-26 Astrazeneca Ab Solid forms comprising a cyclopropyl amide derivative
MX2012009473A (es) 2010-02-18 2012-09-12 Astrazeneca Ab Procesos para preparar derivados de ciclopropilamidas e intermedios asociados con estas.
WO2014087972A1 (ja) * 2012-12-03 2014-06-12 株式会社カネカ 還元型補酵素ｑ10誘導体およびその製造方法
TWI637943B (zh) * 2013-09-05 2018-10-11 田邊三菱製藥股份有限公司 新穎結晶性芳烷基胺化合物及其製造方法
CN111888368B (zh) * 2014-10-21 2024-02-02 武田药品工业株式会社 5-氯-n4-[2-(二甲基磷酰基)苯基]-n2-{2-甲氧基-4-[4-(4-甲基哌嗪-1-基)哌啶-1-基]苯基}嘧啶-2,4-二胺的晶形
CN104958318A (zh) * 2015-08-04 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗感染性疾病的药物舒巴坦钠组合物
AU2017208574B2 (en) * 2016-01-22 2022-09-22 Sandoz Ag Crystalline eravacycline bis-hydrochloride
US10889577B2 (en) 2016-07-07 2021-01-12 Cyclerion Therapeutics, Inc. Solid forms of an sGC stimulator
EP3703686A4 (en) * 2017-10-30 2021-11-17 Theracaine LLC HYDROPHOBIC ARENE SULFONATE SALTS
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
ZA80796B (en) * 1979-02-13 1981-02-25 Leo Pharm Prod Ltd Chemical compounds
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
GB2084572B (en) * 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK162168B (da) 1991-09-23
NO831430L (no) 1983-10-24
NZ203988A (en) 1986-01-24
KR840004437A (ko) 1984-10-15
IE830926L (en) 1983-10-23
FI831392A0 (fi) 1983-04-22
FI76092B (fi) 1988-05-31
DK101783A (da) 1983-10-24
ES8406075A1 (es) 1984-07-01
PT76587A (en) 1983-05-01
FI831392L (fi) 1983-10-24
AU1387183A (en) 1983-11-17
HK20588A (en) 1988-03-25
EG16412A (en) 1989-03-30
DK101783D0 (da) 1983-02-28
KR860001279B1 (ko) 1986-09-05
DD209632A5 (de) 1984-05-16
PL134978B1 (en) 1985-09-30
GR78582B (ko) 1984-09-27
AU536854B2 (en) 1984-05-24
CA1187484A (en) 1985-05-21
SU1138030A3 (ru) 1985-01-30
PH18035A (en) 1985-03-06
YU43170B (en) 1989-04-30
NO156202B (no) 1987-05-04
DE3362502D1 (en) 1986-04-17
FI76092C (fi) 1988-09-09
ZA832845B (en) 1984-11-28
JPS58201792A (ja) 1983-11-24
ES521728A0 (es) 1984-07-01
US4432987A (en) 1984-02-21
IL68453A0 (en) 1983-07-31
YU90483A (en) 1986-04-30
HU187068B (en) 1985-11-28
NO156202C (no) 1987-08-19
DK162168C (da) 1992-03-02
PL241553A1 (en) 1983-11-21
CS235320B2 (en) 1985-05-15
IL68453A (en) 1986-08-31
JPH0119395B2 (ko) 1989-04-11
EP0092968B1 (en) 1986-03-12
IE54628B1 (en) 1989-12-20
PT76587B (en) 1986-02-27
EP0092968A1 (en) 1983-11-02

Similar Documents

Publication Publication Date Title
DE3362502D1 (en) Crystalline benzenesulfonate salts of sultamicillin
GB8515980D0 (en) Mixture of salts
GB2128926B (en) Crystallisation of thermoplastic
YU42767B (en) Process for obtaining crystalline salts of benzothiazin-dioxide
DE3374305D1 (en) Process for the preparation of quaternary ammonium salts
ZA839593B (en) Crystalline cephem-acid addition salts and processes for their preparation
GB8316168D0 (en) Crystalline gallosilicates
PT81274A (en) Process for the preparation of substituted 2-furanylalkoxyalkylcyclimmonium or 5-oxo-2-furanylalkoxyalkycyclimmonium salts
ZA852042B (en) Crystalline ceftazidime salts
PT80999A (en) Process for the preparation of cyclimmonium salts
KE3785A (en) Crystalline benzenesulfonate salts of sultamicillin
DE3462139D1 (en) Process for the preparation of hydroxybenzylphosphonium salts
GB2158828B (en) Salts of fosfomycin
AU553252B2 (en) Crystalline salts of cefodizim
IL69566A0 (en) Crystallizable salts of a thiovinyl cephalosporin derivative and methods for the preparation of same
GB8406435D0 (en) Single crystalline dl-cysteine
EP0201055A3 (en) Process for the preparation of halogenide-free quaternary ammonium salts
GB8302317D0 (en) Crystalline form of sodium
GB8316589D0 (en) Crystalline salts
ZA843438B (en) Bis-alkylphosphonium salts of n-phosphonomethylglycine
PL237537A1 (en) Method of manufacture of crystalline microcellulose
SU1075479A1 (ru) Выпарной аппарат для кристаллизации растворов
GB8329750D0 (en) 5-phenoxybenzoic acid derivatives of pentites